Panchol (Pravastatin Sodium)

Pravastatin sodium, the active ingredient in Panchol, is a HMG-CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol and triglyceride levels in adults at risk for cardiovascular disease. GNH USA supplies Panchol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Panchol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pravastatin sodium is used to manage dyslipidaemia through cholesterol‑lowering pathways.

- Hypercholesterolaemia: reduces low‑density lipoprotein (LDL) cholesterol and total cholesterol levels. - Familial hypercholesterolaemia (heterozygous): improves lipid profile in genetically predisposed patients. - Primary prevention of cardiovascular events: lowers risk of heart attack, stroke and related vascular events in at‑risk adults. - Post‑myocardial infarction secondary ​   secondary    secondary    secondary    secondary    secondary      secondary      ...  …  ...  …  …  … -  …  …  …  …  …  …  …  …  … ​  …  … …  … …  …  …  …  …  …  …  … …  …  …  ...

The        … …  …  ...

...